ANKRD49P3

Across TCGA pan-cancer cohorts, ANKRD49P3 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated ANKRD49P3 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher ANKRD49P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD49P3 expression acts as an unfavorable survival marker.

MESO, ESCA, and LIHC are the cancer types where ANKRD49P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.036	0.602	<.001	72	view →
ESCA	OS	Quartile	II,III,IV	0.323	0.606	.014	55	view →
LIHC	OS	Tertile	All	0.441	0.793	.001	54	view →
LUAD	DFS	Tertile	III,IV	0.321	0.664	.001	45	view →
KICH	OS	Tertile	All	0.155	0.926	<.001	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
UCEC	OS	Tertile	III,IV	0.262	0.618	.028	30	view →
KIRP	DFS	Tertile	All	0.663	0.925	.001	24	view →
SKCM	OS	Tertile	III,IV	0.557	0.808	.028	18	view →
KIRC	DFS	Tertile	IV	0.266	0.616	.019	18	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

ANKRD49P3–MESO (OS)

Open the MESO breakdown →